Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Mubritinib> ?p ?o }
Showing triples 1 to 66 of
66
with 100 triples per page.
- Mubritinib abstract "Mubritinib (TAK-165) is a protein kinase inhibitor which was under development by Takeda for the treatment of cancer. It completed phase I clinical trials but appears to have been discontinued, as no new information on the drug has surfaced since December 2008.".
- Mubritinib atcPrefix "none".
- Mubritinib casNumber "366017-09-6".
- Mubritinib fdaUniiCode "V734AZP9BR".
- Mubritinib iupacName "1-(4-{4-[(2-{(E)-2-[4-(trifluoromethyl)phenyl]ethenyl}-1,3-oxazol-4-yl)methoxy]phenyl}butyl)-1H-1,2,3-triazole".
- Mubritinib pubchem "6444692".
- Mubritinib thumbnail Mubritinib_2.svg?width=300.
- Mubritinib wikiPageID "26920239".
- Mubritinib wikiPageLength "2919".
- Mubritinib wikiPageOutDegree "10".
- Mubritinib wikiPageRevisionID "667233629".
- Mubritinib wikiPageWikiLink Cancer.
- Mubritinib wikiPageWikiLink Category:Oxazoles.
- Mubritinib wikiPageWikiLink Category:Triazoles.
- Mubritinib wikiPageWikiLink Category:Tyrosine_kinase_inhibitors.
- Mubritinib wikiPageWikiLink Clinical_trial.
- Mubritinib wikiPageWikiLink Protein_kinase_inhibitor.
- Mubritinib wikiPageWikiLink Takeda_Pharmaceutical_Company.
- Mubritinib wikiPageWikiLink File:Mubritinib.png.
- Mubritinib wikiPageWikiLinkText "Mubritinib".
- Mubritinib atcPrefix "none".
- Mubritinib c "25".
- Mubritinib casNumber "366017".
- Mubritinib chembl "1614707".
- Mubritinib chemspiderid "4948554".
- Mubritinib f "3".
- Mubritinib h "23".
- Mubritinib iupacName "1".
- Mubritinib iupharLigand "6011".
- Mubritinib legalStatus "Uncontrolled".
- Mubritinib molecularWeight "468.47".
- Mubritinib n "4".
- Mubritinib o "2".
- Mubritinib pubchem "6444692".
- Mubritinib routesOfAdministration "Oral".
- Mubritinib smiles "FCc1ccc\C=C\c2ncCOc3cccCCCCn4nncc4".
- Mubritinib unii "V734AZP9BR".
- Mubritinib width "250".
- Mubritinib wikiPageUsesTemplate Template:Drugbox.
- Mubritinib wikiPageUsesTemplate Template:Extracellular_chemotherapeutic_agents.
- Mubritinib wikiPageUsesTemplate Template:Fdacite.
- Mubritinib wikiPageUsesTemplate Template:Intracellular_chemotherapeutic_agents.
- Mubritinib wikiPageUsesTemplate Template:Reflist.
- Mubritinib subject Category:Oxazoles.
- Mubritinib subject Category:Triazoles.
- Mubritinib subject Category:Tyrosine_kinase_inhibitors.
- Mubritinib hypernym Inhibitor.
- Mubritinib type ChemicalSubstance.
- Mubritinib type Drug.
- Mubritinib type Azole.
- Mubritinib type Drug.
- Mubritinib type Heterocycle.
- Mubritinib type Inhibitor.
- Mubritinib type ChemicalObject.
- Mubritinib type Thing.
- Mubritinib type Q8386.
- Mubritinib comment "Mubritinib (TAK-165) is a protein kinase inhibitor which was under development by Takeda for the treatment of cancer. It completed phase I clinical trials but appears to have been discontinued, as no new information on the drug has surfaced since December 2008.".
- Mubritinib label "Mubritinib".
- Mubritinib sameAs Q6930896.
- Mubritinib sameAs m.0bmh5nz.
- Mubritinib sameAs Mubritinib.
- Mubritinib sameAs Mubritinib.
- Mubritinib sameAs Q6930896.
- Mubritinib wasDerivedFrom Mubritinib?oldid=667233629.
- Mubritinib depiction Mubritinib_2.svg.
- Mubritinib isPrimaryTopicOf Mubritinib.